{"nct_id":"NCT01659047","title":"A Phase 2, Single-Arm, Open-Label Study Evaluating the Efficacy and Safety of Single Agent GS 1101 (CAL 101) as Therapy for Previously Treated Chronic Lymphocytic Leukemia","status":"WITHDRAWN","status_verified_date":"2012-09","start_date":"2012-08","start_date_type":null,"primary_completion_date":"2014-12","primary_completion_date_type":"ESTIMATED","completion_date":"2015-12","completion_date_type":"ESTIMATED","phases":["PHASE2"],"tickers":["GILD"]}